Pictured: Cancer cell lines
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, August 26, 2013

A recent study found that the cell lines most commonly used for research on ovarian cancer are not the most suitable.

Pictured: Barbara Raphael & Chioma Enweasor
Learning Curve
By Christina Pernambuco-Holsten, MA  |  Friday, August 23, 2013

Our summer fellowship program helps medical students learn to become physician-scientists. Read about one of our trainees who investigated an imaging tool for use in patients with a rare uterine cancer.

Pictured: Robert J. Motzer
In the Clinic
By Maureen Salamon, BA, Freelance Writer  |  Thursday, August 22, 2013

An international study led by Memorial Sloan Kettering found that pazopanib (Votrient®) controls cancer as effectively as sunitinib (Sutent®) while improving patients’ quality of life.

Pictured: Micropapillary Morphology
In the Lab
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, August 9, 2013

A Memorial Sloan Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.

Pictured: Clostridium difficile
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, August 7, 2013

Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.

Pictured: Luciano Martelotto, Catherine Cowell & Jorge Reis-Filho
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Monday, August 5, 2013

Jorge Reis-Filho studies the genetic alterations that drive the malignant behavior of cells in rare types of breast cancer.

Perspective
By Paul Sabbatini, MD, Deputy Physician-in-Chief for Clinical Research  |  Friday, July 26, 2013

The clinical trial remains our best tool to identify new therapies, but as with all tools, innovation is required if trials are to remain relevant.

Pictured: Scott Lowe & Zhen Zhao
Video
By Eva Kiesler, PhD and Allyson Collins, MS
Friday, July 19, 2013

Watch our scientists discuss how the Geoffrey Beene Center helped Memorial Sloan Kettering establish a progressive approach to modern cancer research.

Pictured: Scott Armstrong, Michael Kuehn, Haijhua Chu, Monica Cusan & Andrei Kritsov
Profile
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, July 12, 2013

Scott Armstrong specializes in the treatment of leukemia in children. His research focuses on the disease in children and adults.

Pictured: 2013 Graduates
Feature
By Celia Gittelson, BA  |  Monday, July 8, 2013

Honors were conferred, PhD degrees were awarded, and a Pulitzer Prize-winning author addressed the graduates at the May 10 ceremony.

Pictured: Christina Leslie
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Friday, June 28, 2013

Christina Leslie develops computational and statistical methods to study gene expression in normal cells and in cancer cells.

In the Clinic
By Memorial Sloan Kettering  |  Wednesday, June 19, 2013

A Memorial Sloan Kettering study suggests that lymphedema of the arm, a swelling that can occur following breast cancer treatment, may be reduced by acupuncture.

Pictured: Jedd Wolchok & Richard Carvajal
In the Clinic
By Media Staff  |  Monday, June 3, 2013

Two Memorial Sloan Kettering studies that hold promise for the treatment of advanced uveal (eye) melanoma and advanced skin melanoma are making headlines at the 49th Annual Meeting of the American Society of Clinical Oncology.

Pictured: Three-dimensional structure of the protein mTOR
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, May 30, 2013

In an eagerly awaited study, Memorial Sloan Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer.

Pictured:  Timothy Chan
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Friday, May 24, 2013

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.

Center News

Stay Informed

Get the latest information about cancer care and research every month.